- Home
- BCYC vs ASPN Comparison
BCYC vs ASPN Comparison
Compare BCYC & ASPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCYC
- ASPN
- Stock Information
- Founded
- BCYC 2009
- ASPN 2001
- Country
- BCYC United Kingdom
- ASPN United States
- Employees
- BCYC N/A
- ASPN N/A
- Industry
- BCYC Biotechnology: Pharmaceutical Preparations
- ASPN RETAIL: Building Materials
- Sector
- BCYC Health Care
- ASPN Consumer Discretionary
- Exchange
- BCYC Nasdaq
- ASPN Nasdaq
- Market Cap
- BCYC 565.5M
- ASPN 573.2M
- IPO Year
- BCYC 2019
- ASPN 2014
- Fundamental
- Price
- BCYC $8.76
- ASPN $7.53
- Analyst Decision
- BCYC Buy
- ASPN Buy
- Analyst Count
- BCYC 11
- ASPN 7
- Target Price
- BCYC $22.91
- ASPN $17.50
- AVG Volume (30 Days)
- BCYC 284.7K
- ASPN 2.0M
- Earning Date
- BCYC 10-31-2025
- ASPN 11-06-2025
- Dividend Yield
- BCYC N/A
- ASPN N/A
- EPS Growth
- BCYC N/A
- ASPN N/A
- EPS
- BCYC N/A
- ASPN N/A
- Revenue
- BCYC $19,281,000.00
- ASPN $397,175,000.00
- Revenue This Year
- BCYC N/A
- ASPN N/A
- Revenue Next Year
- BCYC N/A
- ASPN $8.56
- P/E Ratio
- BCYC N/A
- ASPN N/A
- Revenue Growth
- BCYC N/A
- ASPN 11.18
- 52 Week Low
- BCYC $6.10
- ASPN $4.16
- 52 Week High
- BCYC $25.39
- ASPN $19.32
- Technical
- Relative Strength Index (RSI)
- BCYC 56.40
- ASPN 48.06
- Support Level
- BCYC $7.65
- ASPN $7.62
- Resistance Level
- BCYC $8.75
- ASPN $8.64
- Average True Range (ATR)
- BCYC 0.45
- ASPN 0.47
- MACD
- BCYC -0.03
- ASPN -0.08
- Stochastic Oscillator
- BCYC 55.56
- ASPN 4.90
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About ASPN Aspen Aerogels Inc.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.